{"id":461632,"date":"2026-08-03T10:36:38","date_gmt":"2026-08-03T08:36:38","guid":{"rendered":"https:\/\/www.eunews.it\/2026\/08\/03\/dalla-bei-20-milioni-di-euro-ad-aiforia-per-la-ricerca-sui-tumori\/"},"modified":"2026-08-03T11:39:46","modified_gmt":"2026-08-03T09:39:46","slug":"eib-grants-20-million-euro-to-aiforia-for-cancer-research","status":"publish","type":"post","link":"https:\/\/www.eunews.it\/en\/2026\/08\/03\/eib-grants-20-million-euro-to-aiforia-for-cancer-research\/","title":{"rendered":"EIB grants 20\u202fmillion euro to Aiforia for cancer research"},"content":{"rendered":"<p>Brussels \u2013 &nbsp;The European Investment Bank (EIB) has signed today (3 August) a&nbsp;20 million euro&nbsp;venture debt <a href=\"https:\/\/www.eib.org\/en\/press\/all\/2026-268-aiforia-lands-eu-financing-to-develop-ai-powered-cancer-detection\" target=\"_blank\" rel=\"noopener\">financing agreement <\/a> \u2013 a loan granted to innovative start-ups or growing companies already backed by equity funds \u2013 to Aiforia, a Finnish company specialising in the development of artificial intelligence software and cloud technologies for digital pathology \u2013 the medical technique that&nbsp;converts traditional glass tissue slides into high\u2011resolution digital images. <strong>The funding will support the development of an artificial intelligence-based platform, used primarily for the detection of tumours.<\/strong> Specifically, the software analyses ultra-high-resolution images of biopsy samples \u2013 small fragments of tissue or clusters of cells taken from a living organism for examination under a microscope \u2013 to identify cancer cells with high precision and speed.&nbsp;<\/p>\n<p><strong>The EIB\u2019s support for Aiforia forms part of the European Commission\u2019s <a href=\"https:\/\/investeu.europa.eu\/index_en\" target=\"_blank\" rel=\"noopener\">InvestEU<\/a> programme<\/strong>, which&nbsp;mobilises investment, supports economic recovery, and finances the green and digital transitions. Aiforia plans to use the funding to \u201caccelerate product development, expand our commercial operations<em>.&#8221;<\/em> The funding is divided into three tranches, the first of which is worth 5 million euros. The disbursement of each instalment is, however, conditional upon the achievement of turnover targets and other interim targets set out in the financing agreement.&nbsp;<\/p>\n<p>&#8220;Our continent is working to remain competitive, and we need to support the companies that make that possible,&#8221; said EIB Vice-President <strong>Karl Nehammer<\/strong>, emphasising that &#8220;Europe must have the best technologies developed in-house to protect and care for its citizens.&#8221; &nbsp;Aiforia\u2019s CEO, <strong>Jukka Tapaninen<\/strong>, added: \u201cWith this financing, we can accelerate product development, expand our commercial operations internationally, and advance our goal of improving patient care through AI-powered image analysis solutions.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brussels \u2013 &nbsp;The European Investment Bank (EIB) has signed today (3 August) a&nbsp;20 million euro&nbsp;venture debt financing agreement \u2013 a loan granted to innovative start-ups or growing companies already backed by equity funds \u2013 to Aiforia, a Finnish company specialising in the development of artificial intelligence software and cloud technologies for digital pathology \u2013 the [&hellip;]<\/p>\n","protected":false},"author":7908,"featured_media":461609,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"episode_type":"","audio_file":"","podmotor_file_id":"","podmotor_episode_id":"","cover_image":"","cover_image_id":"","duration":"","filesize":"","filesize_raw":"","date_recorded":"","explicit":"","block":"","jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard","override":[{"template":"1","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"0","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","show_comment_section":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0","subtitle":""},"jnews_primary_category":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[30961,25774],"tags":[25821,25911,26590,35160,35161,26641],"class_list":["post-461632","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salute-en","category-in-brief","tag-artificial-intelligence-en","tag-bei-en","tag-finlandia-and","tag-istituto-di-ricerca","tag-patologia","tag-tumori-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/posts\/461632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/comments?post=461632"}],"version-history":[{"count":1,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/posts\/461632\/revisions"}],"predecessor-version":[{"id":461633,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/posts\/461632\/revisions\/461633"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/media\/461609"}],"wp:attachment":[{"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/media?parent=461632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/categories?post=461632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eunews.it\/en\/wp-json\/wp\/v2\/tags?post=461632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}